Wilmington Pharmaceuticals logo — company profile

Wilmington Pharmaceuticals

Founded 2002 1 employees Series B Total: $1.30M Biotechnology, Health Care

General Information

Company Name Wilmington Pharmaceuticals
Founded Year 2002
Employees 1
Industries Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Wilmington Pharmaceuticals. To contact Wilmington Pharmaceuticals, visit wilmingtonpharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Wilmington Pharmaceuticals compare?

A PDF of Wilmington Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Wilmington Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Wilmington Pharmaceuticals

Wilmington Pharmaceuticals is a biotechnology and healthcare startup founded in 2002. The company specializes in creating and licensing patient-friendly, fast-dissolving formulations for existing medicines, ultimately streamlining the FDA approval process and ensuring swift market entry for their partners. With a recent $1.30M Series B investment on 26 October 2006 from Wilmington Investor Network and Emergent Growth Fund, the company is poised for expansion and further development in the industry. Leveraging their unique capabilities, Wilmington Pharmaceuticals stands out as an ideal partner for innovative pharmaceutical development, contributing to regulatory optimization and financial success. While the company's headquarters location remains unspecified, this recent investment highlights their potential for growth and prominence in the healthcare sector.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $1.30M 2
Wilmington Investor Network, Emergent Growth Fund
26 Oct 2006

Wilmington Pharmaceuticals Alternatives & Competitors

Wilmington Pharmaceuticals vs

Empowering patients with innovative, noninvasive solutions for long-term cerebral health and reduced...

Seed
11-50 employees
Biotechnology, Health Care

FAQ About Wilmington Pharmaceuticals

Wilmington Pharmaceuticals creates and licenses patient-friendly, fast-dissolving formulations for existing medicines. They secure FDA approval and achieve swift market entry for their partners, reducing regulatory challenges while optimizing financial gains. Their unique capabilities make them the...
Wilmington Pharmaceuticals was founded in 2002.
Wilmington Pharmaceuticals operates in Biotechnology and Health Care.
Wilmington Pharmaceuticals has approximately 1 employees.
Wilmington Pharmaceuticals has completed 1 funding round, raising a total of $1.30M. The latest funding stage is Series B.
Top alternatives and competitors to Wilmington Pharmaceuticals include Anuncia Medical Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Wilmington Pharmaceuticals and Anuncia Medical Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Wilmington Pharmaceuticals, https://bouncewatch.com/company/wilmington-pharmaceuticals, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes